Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This method ensures compliance , security , and continuity of service for all customers across the EU
Tirzepatide is a dual GIP/GLP-1 receptor agonist administered once weekly for type 2 diabetes management
It is dispensed in amber multidose vials containing 1,000 mcg/mL and compounded for use under either section 503A or 503B, allowing clinicians to individualize therapy for deficiency states ranging from pernicious anemia to postsurgical malabsorption
Compounded Tirzepatide $125/month Compounded Semaglutide $99/month Why choose Trimi
US$ 20.27
US$ 20.57
US$ 20.94
US$ 24.23
US$ 21.59
